DSE : AMBEEPHA

Ambee Pharmaceuticals PLC — Financial statements

Pharmaceutical Preparations · Bangladesh

Last price 730.7 BDT (At close: Oct 29, 2026) · Market cap 1.75B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Financial statements

Ambee Pharmaceuticals PLC (AMBEEPHA) reported revenue of 157.61M BDT (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue157.61M230.55M219.30M198.10M180.99M98.98M
Cost of Revenue84.67M119.16M103.14M92.53M83.62M58.27M
Gross Profit72.95M111.39M116.16M105.56M97.37M40.71M
Selling, General & Admin68.89M104.00M103.75M92.39M82.51M47.99M
Operating Expenses68.89M104.00M103.75M92.39M82.51M47.99M
Operating Income4.06M7.39M12.41M13.17M14.86M-7.28M
Interest Expense-33.80K-88.80K-579.85K-2.49M-4.62M-5.00M
Interest & Investment Income3.60M
Other Non Operating Income (Expenses)2.00K1.00-1.002.00
EBT Excluding Unusual Items7.62M7.30M11.83M10.68M10.23M-12.28M
Pretax Income7.62M7.30M11.83M10.68M10.23M-12.28M
Income Tax Expense2.10M1.99M2.15M1.59M2.18M731.16K
Net Income5.53M5.31M9.68M9.09M8.06M-13.01M
Net Income to Common5.53M5.31M9.68M9.09M8.06M-13.01M
Shares Outstanding (Basic)2.40M2.40M2.40M2.40M2.40M2.40M
Shares Outstanding (Diluted)2.40M2.40M2.40M2.40M2.40M2.40M
EPS (Basic)2.302.214.033.793.36-5.42
EPS (Diluted)2.302.214.033.793.36-5.42
Free Cash Flow-18.41M-2.06M-68.12M-35.34M-74.71M-5.45M
Free Cash Flow Per Share-7.67-0.86-28.39-14.72-31.13-2.27
Dividend Per Share1.001.001.001.501.00
Gross Margin46.28%48.31%52.97%53.29%53.80%41.13%
Operating Margin2.57%3.21%5.66%6.65%8.21%-7.36%
Profit Margin3.51%2.30%4.42%4.59%4.45%-13.14%
Free Cash Flow Margin-11.68%-0.89%-31.06%-17.84%-41.28%-5.51%
EBITDA8.50M12.46M18.26M20.16M19.64M-1.67M
EBITDA Margin5.39%5.40%8.32%10.18%10.85%-1.69%
D&A For EBITDA4.44M5.07M5.84M6.99M4.79M5.61M
EBIT4.06M7.39M12.41M13.17M14.86M-7.28M
EBIT Margin2.57%3.20%5.66%6.65%8.21%-7.36%
Effective Tax Rate27.49%27.26%18.16%14.90%21.25%
Advertising Expenses819.90K1.12M1.43M4.58M930.69K

Balance sheet

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents34.80M32.64M32.74M28.57M16.92M15.09M
Short-Term Investments63.06M100.00M
Cash & Short-Term Investments97.86M132.64M32.74M28.57M16.92M15.09M
Receivables221.35M194.84M180.65M135.94M112.51M92.23M
Inventory248.40M210.80M221.91M197.25M178.89M128.89M
Prepaid Expenses25.00K25.00K25.00K25.00K25.00K25.00K
Other Current Assets41.69M39.27M69.52M64.65M100.76M85.62M
Total Current Assets609.33M577.57M504.84M426.44M409.11M321.85M
Property, Plant & Equipment96.54M103.38M85.10M87.61M95.04M99.56M
Long-Term Investments52.60M52.60M
Other Long-Term Assets1.00
Total Assets758.48M733.56M589.94M514.05M504.15M421.42M
Accounts Payable4.49M6.13M5.59M4.98M6.55M7.22M
Accrued Expenses32.65M31.72M20.23M19.65M53.02M79.04M
Short-Term Debt660.15M638.50M392.35M343.80M235.67M
Current Portion of Leases52.00K237.24K596.46K126.40K1.07M2.75M
Current Income Taxes Payable20.84M18.41M25.16M31.54M36.34M38.44M
Current Unearned Revenue4.62M
Other Current Liabilities1.35M2.18M499.56M35.93M3.49M5.00M
Total Current Liabilities719.53M697.17M555.76M484.59M444.27M368.12M
Long-Term Leases198.00K201.55K244.58K9.90K1.42M
Long-Term Deferred Tax Liabilities3.38M3.85M4.51M6.12M7.17M7.04M
Other Long-Term Liabilities1.00
Total Liabilities723.12M701.22M560.52M490.71M451.45M376.58M
Common Stock24.00M24.00M24.00M24.00M24.00M24.00M
Retained Earnings11.36M8.33M5.42M-658.81K28.70M20.84M
Shareholders' Equity35.36M32.33M29.42M23.34M52.70M44.84M
Total Liabilities & Equity758.48M733.56M589.94M514.05M504.15M421.42M
Total Debt660.40M638.94M841.03K392.48M344.88M239.85M
Net Cash (Debt)-562.54M-506.30M31.90M-363.91M-327.96M-224.75M
Net Cash Per Share-234.39-210.9613.29-151.63-136.65-93.65
Filing Date Shares Outstanding2.40M2.40M2.40M2.40M2.40M2.40M
Total Common Shares Outstanding2.40M2.40M2.40M2.40M2.40M2.40M
Working Capital-110.21M-119.60M-50.92M-58.15M-35.17M-46.26M
Book Value Per Share14.7313.4712.269.7321.9618.68
Tangible Book Value35.36M32.33M29.42M23.34M52.70M44.84M
Tangible Book Value Per Share14.7313.4712.269.7321.9618.68
Land50.25M50.25M50.25M50.25M50.25M50.25M
Buildings29.95M29.95M29.95M29.95M29.95M29.08M
Machinery174.25M174.25M150.46M148.26M148.15M147.49M

Cash flow statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income5.53M5.31M9.68M9.09M8.06M-13.01M
Depreciation & Amortization5.13M5.51M6.05M7.54M6.05M6.92M
Other Operating Activities25.20M2.00-2.00-37.09M-86.05K-318.49K
Change in Accounts Receivable-40.02M-14.19M-45.63M-23.43M-20.28M-23.08M
Change in Inventory-26.49M11.11M-24.67M-18.36M-50.00M31.37M
Change in Accounts Payable538.04K538.04K605.47K-1.57M-665.10K-2.84M
Change in Income Taxes-7.84M-7.27M-9.71M22.13M-2.75M1.05M
Change in Other Net Operating Assets19.53M20.72M-2.26M6.46M-13.51M-5.54M
Operating Cash Flow-18.41M21.73M-65.92M-35.23M-73.18M-5.45M
Capital Expenditures254.00-23.79M-2.20M-106.75K-1.53M
Investment in Securities-15.66M-152.60M
Other Investing Activities60.00K60.00K
Investing Cash Flow-15.60M-176.34M-2.20M-106.75K-1.53M
Short-Term Debt Issued161.94M81.82M101.48M132.69M10.62M
Long-Term Debt Issued714.64K
Total Debt Issued36.61M161.94M82.53M101.48M132.69M10.62M
Short-Term Debt Repaid-11.48M-52.54M-51.56M
Long-Term Debt Repaid-402.25K-955.51K-3.09M-865.82K
Total Debt Repaid-327.25K-402.25K-11.48M-53.50M-54.65M-865.82K
Net Debt Issued (Repaid)36.28M161.54M71.05M47.98M78.04M9.76M
Common Dividends Paid-2.18M-2.35M-3.38M-1.00M-1.50M-326.49K
Other Financing Activities-4.12M-4.62M4.62M
Financing Cash Flow29.98M154.56M72.30M46.98M76.54M9.43M
Miscellaneous Cash Flow Adjustments-60.00K-60.00K1.00
Net Cash Flow-4.09M-100.05K4.17M11.64M1.83M3.98M
Free Cash Flow-18.41M-2.06M-68.12M-35.34M-74.71M-5.45M
Free Cash Flow Margin-11.68%-0.89%-31.06%-17.84%-41.28%-5.51%
Free Cash Flow Per Share-7.67-0.86-28.39-14.72-31.13-2.27
Levered Free Cash Flow-24.38M-483.28M400.07M1.12M-104.80M-2.47M
Unlevered Free Cash Flow-24.36M-483.22M400.43M2.68M-101.91M649.22K
Cash Interest Paid335.57K390.57K1.93M3.69M5.77M5.82M
Cash Income Tax Paid5.41M5.50M14.49M15.47M5.85M-31.12M
Change in Working Capital-54.27M10.91M-81.65M-14.77M-87.21M957.84K

Ratios

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.75B1.96B1.83B1.32B1.26B985.20M
Enterprise Value2.32B2.45B2.24B1.63B1.52B1.20B
Last Close Price730.70815.42760.13546.57521.71407.85
PE Ratio317.27369.08188.91144.97156.37
PS Ratio11.138.508.346.656.969.95
PB Ratio49.6060.6062.1756.4623.9221.97
P/TBV Ratio49.6060.6062.1756.4623.9221.97
P/OCF Ratio90.16
EV/Sales Ratio14.7010.6110.228.228.4012.14
EV/EBITDA Ratio261.56196.29122.7380.7977.41
EV/EBIT Ratio330.94180.50123.64102.35
Debt / Equity Ratio18.6819.760.0316.826.545.35
Debt / EBITDA Ratio74.5849.530.0518.9516.49
Net Debt / Equity Ratio15.9115.66-1.0815.596.225.01
Net Debt / EBITDA Ratio66.2040.65-1.7518.0516.70-134.45
Net Debt / FCF Ratio-30.56-245.760.47-10.30-4.39-41.23
Asset Turnover0.210.350.400.390.390.23
Inventory Turnover0.350.550.490.490.540.40
Quick Ratio0.440.470.380.340.290.29
Current Ratio0.850.830.910.880.920.87
Return on Equity (ROE)16.36%17.19%36.70%23.91%16.53%-25.34%
Return on Assets (ROA)0.34%0.70%1.41%1.62%2.01%-1.07%
Return on Invested Capital (ROIC)0.50%1.00%2.92%3.60%-2.68%
Return on Capital Employed (ROCE)10.40%20.30%36.30%44.70%24.80%-13.70%
Earnings Yield0.32%0.27%0.53%0.69%0.64%-1.32%
FCF Yield-1.05%-0.10%-3.72%-2.68%-5.93%-0.55%
Dividend Yield0.14%0.12%0.13%0.27%0.19%
Payout Ratio39.37%44.23%34.91%11.00%18.61%
Total Shareholder Return0.14%0.12%0.13%0.27%0.19%